The International Conference on Biotechnology in Health Science and Therapeutics (ICBHST2025) seeks original research contributions across various disciplines, provided the work's context is adequately articulated. Researchers are encouraged to submit their papers by the specified deadline. After this date, no new papers will be accepted for submission, although modifications to existing submissions will still be possible. This conference aims to bring together leading experts to discuss and share innovative ideas and advancements of biotechnology in health science and therapeutics.
Paper Submission Link: https://cmt3.research.microsoft.com/ICBHST2025
Paper Template: Download File
The Microsoft CMT service was used for managing the peer-reviewing process for this conference. This service was provided for free by Microsoft and they bore all expenses, including costs for Azure cloud services as well as for software development and support.
All submissions for ICBHST2025 will be managed through emails. By submitting, the authors agree to ICBHST2025's policies. Each submission will receive a unique paper ID, which should be used in all communications. Kindly remember the paper ID and quote that ID in all further communications in the subject line when you email us your query.
Articles with novel research contributions on the conference's theme should be submitted to ICBHST2025.
The default language style at ICBHST2025 is standard English language only. Authors should submit manuscripts in English only.
The conference committee maintains strict confidentiality throughout the process, from submission to decision-making on every article considered for review. Reviewers involved in this whole review process are from reputed universities throughout the globe, and the practice of keeping all information confidential during the review is part of the standard communication with all reviewers.
Once a structured abstract is submitted to the conference, the authors agree to our review policy, where the article will be peer-reviewed by professional reviewers after being checked for similarity index and plagiarism by plagiarism detection software (Turnitin). ICBHST2025 respects Intellectual Property Rights. Plagiarism is defined as the incorrect appropriation of someone else's information, thoughts, or ideas and presenting them as one's own. The conference committee will not tolerate this sort of breach of ethical norms at any cost. Any article with more than 15% similarity index will be rejected immediately without further consideration. The similarity should not be greater than 2% from a single source.
Our conference aims to present novel research and ensure efficient use of reviewers' efforts. Authors submitting manuscripts acknowledge that their work has not been previously published or accepted for publication in a substantially similar form in any peer-reviewed venue. Any breach of these conditions will result in rejection and notification to the other venue where the submission was made. Submissions should be original and not duplicate prior publications or ongoing submissions. Include citations in your manuscript if you need to reference another paper concurrently submitted to the conference. Clearly articulate in your paper how your submission differs significantly from these concurrent works and provide the additional papers in the supplemental material. Authors are encouraged to contact the Program Chairs for further clarification if needed.
The authors must agree that if the structured abstract is accepted, at least one of the authors will register for the conference and present the paper there. Acceptance of a structured abstract does not claim for final publication. Only presented papers will be forwarded to the publication partner. Presenters will be provided with a certificate of paper presentation.
All accepted structured abstract will be published in the conference proceedings with an ISBN. Based on the quality and relevance of the abstract submissions, the review panel may recommend suitable full-length paper for consideration in the above-mentioned journals and book series. However, the final acceptance for publication will solely depend on the independent peer-review process of the respective journal and book series.
All articles submitted to the conference cannot be fully or partially publicised on any social media platform until an official acceptance email is received from the publisher. If any author(s) violate this act, their article will be rejected for presentation and removed from the proceeding for publication.
